Multifocal Breast Carcinoma
4 clinical trials · Condition
◉ Watch Multifocal Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer (NCT04481113) | OHSU Knight Cancer Institute | 2021-06-07 |
| T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial (NCT04457596) | Alliance for Clinical Trials in Oncology | 2021-03-02 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer (NCT03128619) | Jonsson Comprehensive Cancer Center | 2017-08-02 |
| Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer (NCT01272037) | National Cancer Institute (NCI) | 2011-02-28 |
Track Multifocal Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.